Influenza A virus Protein Features:

PB2: aa 1-759 (H1N1, A/PR/8/34, UniProt)

Structural domains/motifs.

PB2 cap-binding domain: aa 318–483
PB2 host adaptation domain: aa 538-676
NLS: aa 687-759

Pathogenecity: K627 in human influenza strains (e.g. A/Los Angeles/2/87 (H5N1)) , is E627 in avian strains (e.g. A/Mallard/NY/78 virus (H2N2))


Phosphorylation Sites: S742




PB2-S1: aa 1-510 (H1N1, A/PR/8/34, UniProt)



PB1: aa 1-757 (H1N1, A/PR/8/34, UniProt)

N-terminal interaction with PA: aa 1-25
C-terminal interaction with PB2 N-terminus: aa 678-757
Phosphorylations Sites: T223


PB1-N40:aa 1-717



PB1-F2: aa 1-87

Note that most H1N1 strains produce a truncated version of 57aa in length or none. human H3N2 or avian H5N1 produce full-length 87-90aa proteins. Rarely up to 101aa in length in some strains (mainly human H3N2).

N-terminal domain: 1-40
C-terminal domain: 50-87

Amphipathic helix: aa 69-83

Protein stability: aa 68-71


PA: aa 1-716 (H1N1, A/PR/8/34, UniProt)

N-terminal endonuclease domain: aa 1-198 - involved in binding PB2
C-terminal domain: aa 254-716 - involved in binding PB1

Phosphorylation Sites: S224/S225


PA-N155: aa 1-562



PA-N182: aa 1-535



PA-X: aa 1-252

C-terminal region: 192-252

Frameshift (+1) motif: UCC UUU C*GU C
                       UCC UUU  GUC - C* at position 191 is not read for PA-X translation.

C-terminal residues important for suppression of host gene expression: aa 233-252 (not found in 2009pdm H1N1).

Residues important for shutoff function: R195, K198, R199, K202, K203, K206.


HA: aa 1-565 (H1N1, A/PR/8/34, UniProt)

Signal peptide: MKANLLVLLCALAAADA (H1N1, GenBank/UniProt)

Cleavage site (HACS): Varies depending on host species and between strains. Monobasic HACS associated with low-pathogenecity in avian strains. Polybasic associated with high-pathogenecity. Pathogenecity of avian strains is generally low but H5 or H7 variants can mutate into high-pathogenecity variants.
Leaves HA0 converted into HA1 and HA2 which are 327 and 222 aa in length respectively.

R343, at cleavage site, is highly conserved.

PS----IQSR/G (H1N1, aa 338-344)
PEIPKRKRR/GLF (avian H7N7)
PQRERRRKKR/G (A/Hong Kong/483/97)


### Features


HA1: DTICIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDSHNGKLCRLKGIAPLQLGKCNIAGWLLGNPECDPLLPVRSWSYIVETPNSENGICYPGDFIDYEELREQLSSVSSFERFEIFPKESSWPNHNTNGVTAACSHEGKSSFYRNLLWLTEKEGSYPKLKNSYVNKKGKEVLVLWGIHHPPNSKEQQNLYQNENAYVSVVTSNYNRRFTPEIAERPKVRDQAGRMNYYWTLLKPGDTIIFEANGNLIAPMYAFALSRGFGSGIITSNASMHECNTKCQTPLGAINSSLPYQNIHPVTIGECPKYVRSAKLRMVTGLRNIPSIQSR
HA2: GLFGAIAGFIEGGWTGMIDGWYGYHHQNEQGSGYAADQKSTQNAINGITNKVNTVIEKMNIQFTAVGKEFNKLEKRMENLNKKVDDGFLDIWTYNAELLVLLENERTLDFHDSNVKNLYEKVKSQLKNNAKEIGNGCFEFYHKCDNECMESVRNGTYDYPKYSEESKLNREKVDGVKLESMGIYQILAIYSTVASSLVLLVSLGAISFWMCSNGSLQCRICI

Fusion peptide: HA2 aa 1-23 GLFGAIAGFIEGGWTG-MI-DGWYG (H1N1, MI vary depending on strain). aa 15 in this sequence varies amongst HA subtypes.
Disulphide bridge: C21-C480, links HA1 and HA2 (H1N1)

Transmembrane region: aa 529-549 (H1N1)

### Variations


Glycosylation Sites: N27/N28, N40, N285, N303, N497 (UniProt)

Palmitolyation Sites: C554, C561, C564 (UniProt)

Phosphorylation Sites: T358 (highly variable residue between HA subtypes).


NP: aa 1-498 (H1N1, A/PR/8/34, UniProt)

Flexible tail-loop: aa 402-428

Phosphorylation Sites: S9/Y10, Y78, S165, T188, Y296/S97, S377/T378, S402/S403, S457, T472/S473


NA: aa 1-454 (H1N1, A/PR/8/34, UniProt)

Phosphorylation Sites: S160/S164/S166


M1: aa 1-252 (H1N1, A/PR/8/34, UniProt)

Phosphorylation Sites: S2/T5, T9/Y10, T37, T108, Y132, T168/T169, S195/S196, S224/S225/S226


M2: aa 1-97 (H1N1, A/PR/8/34, UniProt)

Glycosylation Sites: N20 (UniProt)

Palmitolyation Sites: C50 (UniProt)

Phosphorylation Sites: S64/S65 (Hutchinson et al), S82, S93 (UniProt)


M3:


M4:


M42: aa 1-99


NS1: aa 1-230 (H1N1, A/PR/8/34, UniProt) - range of 215-237aa

N-terminal RNA-binding domain: aa 1-73 - Mutations R38A and K41A abrogate binding.
Linker sequence: aa 74-88
Effector domain: aa 89-202
C-terminal tail: aa 203-237
Nuclear export signal: aa 137-146
Nuclear localisation sequences: aa 35-41 and aa 216-221
Highly conserved sites: F103 and M106 in seasonal human IAV strains (H1N1, H3N2, H2N2) - 99.6% of strains have these. However, our master strain, A/PR/8/34, is one of select few with S103. 10.1073/pnas.0805213105.

Hydrophobic pocket residues involved in CPSF30 binding: aa K110, I117, I119, Q121, V180, G183, G184, and W187 
Residues which influence CPSF30 binding: aa 55, 64, 90, 103, 106, 108, 114, 123, 125, 131, 139, 186, 189, 194, 205 - highly strain dependant.
CPSF30 binding is strain specific and is lacking in A/PR/8/34 and 2009pdm H1N1.

TRIM-25 binding residues: E96/E97 - E96A/E97A abrogate this.

Phosphorylation Sites: T49, Y73, T80, S83


NS3: aa 1-194

Mutation responsible for variant: D125G (corresponds to an A374G substitution in nucleotide sequence, GAT -> GGT)



NEP: aa 1-121 (H1N1, A/PR/8/34, UniProt)

Helices: aa 64-85 (KWREQLGQKFEEIRWLIEEVRH) and 94-115 (FEQITFMQALHLLLEVEQEIRT) (UniProt)
Nuclear Export Signal: aa 12-21 (ILLRMSKMQL) and 85-94 (HKLKITENSF) (UniProt)


NEG8:


References:

Bruns K, Studtrucker N, Sharma A, Fossen T, Mitzner D, Eissmann A, Tessmer U, Röder R, Henklein P, Wray V, Schubert U. Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. J Biol Chem. 2007 Jan 5;282(1):353-63. doi: 10.1074/jbc.M606494200.

Gack MU, Albrecht RA, Urano T, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009;5(5):439-449. doi:10.1016/j.chom.2009.04.006.


=================


